These significant findings not only elucidate the specific regulatory mechanisms of BRCA1/2 mutations on the breast TME but also provide a solid theoretical and experimental foundation for developing precision-targeted therapies for BRCA1/2 mutation-associated breast cancer. Here, BRCA1 is linked to breast cancer.